Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…
Lucid Diligence Brief: kyron.bio x Servier strategic partnership
Lucid Diligence Brief: kyron.bio x Servier strategic partnership Professional…
Lucid Diligence Brief: Formation Bio licenses miR-124 activator FHND5032 from CTFH
Lucid Diligence Brief: Formation Bio licenses miR-124 activator FHND5032 from…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Rare Diseases Weekly News - September 11th 2025
🧬 This Week in Rare Diseases: Servier Fragile X deal, FDA RDEP, Bylvay Canada…
Rare Diseases Weekly News - September 4th 2025
🧬 This Week in Rare Diseases: FDA Approvals, Global Initiatives, and New…
Respiratory Weekly News - August 29th 2025
This Week in Respiratory Health: Breakthroughs in IPF, CF, COPD, MDR-TB, and…
Rare Diseases Weekly News - August 21st 2025
🧬 This Week in Rare Diseases: FDA Approvals, Global Partnerships, Breakthrough…
Rare Diseases Weekly News - August 7th 2025
🧬 This Week in Rare Diseases: Europe’s R&D at Risk, AI Drug Discovery, New…
Hematology Weekly News - July 14th 2025
🔬🧬 Hematology Updates: AbbVie’s $1.9B Myeloma Deal, 92% AML Remission, India…
Immunology Weekly News - July 9th 2025
🧠 This Week in Immunology: RA Market Growth, AI in Care, Breakthroughs in AD,…
Respiratory Weekly News - May 23rd 2025
Lung & Respiratory Breakthroughs: IPF Therapies, Asthma Innovations, COPD…